NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.64
-0.91 (-2.98%)
At close: Jul 24, 2026, 4:00 PM EDT
30.09
+0.45 (1.52%)
After-hours: Jul 24, 2026, 7:58 PM EDT
NAMS Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $50.12. The average 1-year stock price forecast is 69.10% higher than the current stock price, while the lowest is $36.73 (+23.92%) and the highest is $58.22 (+96.42%).
Price Target: $50.12 (+69.10%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 11 | 11 | 11 | 11 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $48 | Buy | Maintains | $48 | +61.94% | Jul 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $48 → $52 | Buy | Reiterates | $48 → $52 | +75.44% | Jul 24, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 24, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $32 → $58 | Buy | Initiates | $32 → $58 | +95.68% | Jul 20, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $47 → $51 | Buy | Maintains | $47 → $51 | +72.06% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
27.72M
from 22.50M
Increased by 23.17%
Revenue Next Year
157.28M
from 27.72M
Increased by 467.47%
EPS This Year
-1.88
from -1.72
EPS Next Year
-1.33
from -1.88
EPS and Forward PE are based on non-GAAP adjusted numbers.